Drug Assessment Framework Shows Promise for Identifying Cancer Drugs |
Using a structured and elicit approach, researchers designed a criterion-based valuation framework to provide a transparent and consistent method with which to value and prioritize cancer drugs to facilitate the delivery of affordable cancer care, according to a report published in Cancer.
|
Read more
|